STOCK TITAN

PTC Therapeutics to Participate at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PTC Therapeutics, based in South Plainfield, N.J., will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 7:30 a.m. PST/10:30 a.m. EST.

The presentation can be accessed via a live webcast on the company’s Investor section and will be archived for 30 days. PTC focuses on developing medicines for rare disorders, aiming to provide access to transformative treatments for patients with unmet medical needs.

Positive
  • None.
Negative
  • None.

SOUTH PLAINFIELD, N.J., Jan. 4, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Monday, Jan. 9, at 7:30 a.m. PST/10:30 a.m. EST.

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-41st-annual-jp-morgan-healthcare-conference-301713827.html

SOURCE PTC Therapeutics, Inc.

FAQ

What is PTC Therapeutics presenting at the J.P. Morgan Healthcare Conference?

PTC Therapeutics will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023.

When and where will PTC's presentation take place?

The presentation will occur on January 9, 2023, at 7:30 a.m. PST (10:30 a.m. EST) in San Francisco.

How can I watch PTC Therapeutics' presentation?

You can watch PTC Therapeutics' presentation via a live webcast on their Investor section at www.ptcbio.com.

Will the PTC Therapeutics presentation be available later?

Yes, the presentation will be archived for 30 days following the live event.

What is the focus of PTC Therapeutics as a company?

PTC Therapeutics is dedicated to developing and commercializing medicines for patients with rare disorders.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN